The Global Brand Lead, Migraine is responsible for defining and driving the global commercial strategy for Ipsen’s migraine franchise. The role's primary accountability is for the launch preparation of Dysport in chronic and episodic migraine and early brand strategy for IPN10200, Ipsen’s next-generation neuromodulator currently in Phase II development. This role will establish migraine as a major new growth pillar for Ipsen, positioning Dysport to redefine the standard of care in episodic migraine and accelerate Ipsen’s expansion in the US and globally. Working in close partnership with the Global Asset Lead, the Global Brand Lead serves as the global commercial architect of the migraine franchise, ensuring that development, evidence generation, market access, and commercialization strategies collectively support a differentiated value proposition versus leading migraine competitors. The role requires understanding of the US migraine market, which represents the largest and most competitive market globally and the primary launch engine for the franchise. The leader will translate deep customer insights and competitive intelligence into global brand strategies that are scalable across priority markets including the US, EU5, and international regions. Benchmarking against best-in-class migraine launches, the Global Brand Lead will build a high-impact launch platform capable of shaping treatment paradigms, driving guideline adoption, and establishing Ipsen as a long-term leader in migraine care. The position combines strategic leadership, launch excellence, and franchise building, with the ultimate goal of creating a sustainable, multi-asset migraine franchise delivering significant global revenue growth and meaningful patient impact.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
1,001-5,000 employees